Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

Gradman, A H; Weir, M R; Wright, M; Bush, C A; Keefe, D L

Gradman, A H; Weir, M R; Wright, M; Bush, C A; Keefe, D L.

Affiliation

Gradman AH; Division of Cardiovascular Diseases, The Western Pennsylvania Hospital, Pittsburgh, PA, USA. gradmanmd@aol.com

J Hum Hypertens ; 24(11): 721-9, 2010 Nov.

Article in En | MEDLINE | ID: mdl-20200550

Subject(s)

Amides/therapeutic use; Antihypertensive Agents/therapeutic use; Blood Pressure/drug effects; Fumarates/therapeutic use; Hypertension/drug therapy; Renin/antagonists & inhibitors; Aged; Amides/adverse effects; Antihypertensive Agents/adverse effects; Dose-Response Relationship, Drug; Female; Fumarates/adverse effects; Humans; Hypertension/metabolism; Hypertension/physiopathology; Middle Aged; Randomized Controlled Trials as Topic; Renin/metabolism; Sex Factors; Time Factors; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Blood Pressure / Renin / Fumarates / Amides / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Hum Hypertens Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google